Oliver Planz

5PUBLICATIONS
5CO-AUTHORS
Innate immunityNanotoxicology, health and safetyMolecular targetsElectrical energy generation (incl. renewables, excl. photovoltaics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jul 15, 2026
MEK Inhibitors and Toll-like Receptor Signaling: Implications for Infection and Inflammation.

|Sep 14, 2024
Special Issue "The Role of Toll-Like Receptors (TLRs) in Infection and Inflammation 2.0".

Ralf Kircheis, Oliver Planz

|Apr 13, 2023
The Role of Toll-like Receptors (TLRs) and Their Related Signaling Pathways in Viral Infection and Inflammation.

Ralf Kircheis, Oliver Planz

|Sep 23, 2022
The MEK1/2 Inhibitor ATR-002 (Zapnometinib) Synergistically Potentiates the Antiviral Effect of Direct-Acting Anti-SARS-CoV-2 Drugs.

André Schreiber, Benjamin Ambrosy, Oliver Planz

|Jun 10, 2022
Could a Lower Toll-like Receptor (TLR) and NF-κB Activation Due to a Changed Charge Distribution in the Spike Protein Be the Reason for the Lower Pathogenicity of Omicron?

Ralf Kircheis, Oliver Planz

Pageof 1

Frequent Collaborators

2 joint publications

Ralf Kircheis

1 joint publications

André Schreiber

1 joint publications

Benjamin Ambrosy

1 joint publications

Ursula Rescher